• Transthoracic impedance and bioreactance analysis Transparency Market Research said the North American market held a major share of the global cardiac output monitoring devices market in 2018. They said this is due to the presence of large population suffering from cardiovascular disorder, rise in hospital admission associated with the disease, and increase in reimbursement scenario for patients suffering from cardiovascular disease in the U.S. Their market analysts said the cardiac output monitoring devices market in Asia Pacific is expected to clock compounded annual growth rate (CAGR) of 5.3% from 2019 to 2027, with the global market's worth to reach about $1.6 billion by 2027.